Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis.
Ferro MT, Steegman JL, Escribano L, Heiurichs B, Parada L, García-Sagredo JM, Resino M, Cabello P, San Román C. Ferro MT, et al. Among authors: steegman jl. Cancer Genet Cytogenet. 1992 Jan;58(1):96-9. doi: 10.1016/0165-4608(92)90143-v. Cancer Genet Cytogenet. 1992. PMID: 1728959
Translocation (11;14) in B-cell lymphoproliferative disorders.
San Román C, Ferro MT, Fernández Rañada JM, Steegman JL. San Román C, et al. Among authors: steegman jl. Cancer Genet Cytogenet. 1982 Dec;7(4):279-86. doi: 10.1016/0165-4608(82)90044-9. Cancer Genet Cytogenet. 1982. PMID: 6897706
Nonclonal abnormalities in leukemia.
Vázquez-Mazariego Y, Ramiro S, Steegman JL, García-Sagredo JM, Sánchez-Hombre MC, Ferro MT. Vázquez-Mazariego Y, et al. Among authors: steegman jl. Cancer Genet Cytogenet. 2000 Apr 1;118(1):85-6. doi: 10.1016/s0165-4608(99)00181-8. Cancer Genet Cytogenet. 2000. PMID: 10766522 No abstract available.
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Sánchez R, Dorado S, Ruíz-Heredia Y, Martín-Muñoz A, Rosa-Rosa JM, Ribera J, García O, Jimenez-Ubieto A, Carreño-Tarragona G, Linares M, Rufián L, Juárez A, Carrillo J, Espino MJ, Cáceres M, Expósito S, Cuevas B, Vanegas R, Casado LF, Torrent A, Zamora L, Mercadal S, Coll R, Cervera M, Morgades M, Hernández-Rivas JÁ, Bravo P, Serí C, Anguita E, Barragán E, Sargas C, Ferrer-Marín F, Sánchez-Calero J, Sevilla J, Ruíz E, Villalón L, Del Mar Herráez M, Riaza R, Magro E, Steegman JL, Wang C, de Toledo P, García-Gutiérrez V, Ayala R, Ribera JM, Barrio S, Martínez-López J. Sánchez R, et al. Among authors: steegman jl. Sci Rep. 2022 Jul 29;12(1):13057. doi: 10.1038/s41598-022-17271-3. Sci Rep. 2022. PMID: 35906470 Free PMC article.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.
16 results